This market insight highlights global healthcare trends and the GCC’s position in relation to these developments. It also assesses opportunities for technology providers with a focus on the penetration potential of key medical technologies. Countries under study are the United Arab Emirates, Saudi Arabia, Qatar, Bahrain, Kuwait, and Oman. Top 3 Predictions Increased private sector
TARRYTOWN, N.Y. — Siemens Healthineers reported today it has achieved 12 Pre-Market Approvals from the Food and Drug Administration for its infectious disease and oncology testing menu. This milestone means the company’s Atellica® Solution1 now provides laboratories in the U.S. with a comprehensive menu on a single laboratory platform for patients’ in vitro diagnostic testing
